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Stent graft composition plays a material role in the
postimplantation syndrome
Michiel T. Voûte, MD,a Frederico M. Bastos Gonçalves, MD,b,d Koen M. van de Luijtgaarden, MD,b
Casper G. A. Klein Nulent, MSc,b Sanne E. Hoeks, PhD,c Robert Jan Stolker, MD, PhD,a and
Hence J. M. Verhagen, MD, PhD,b Rotterdam, The Netherlands; and Lisbon, Portugal
Objective: In patients undergoing endovascular aneurysm repair (EVAR), the postimplantation syndrome (PIS), com-
prising fever and inflammation, occurs frequently. The cause of PIS is unclear, but graft composition and acute thrombus
formation may play a role. The objective of this study was to evaluate these possible causes of the inflammatory response
after EVAR.
Methods: One hundred forty-nine patients undergoing elective EVAR were included. Implanted stent grafts differed
mainly in the type of fabric used: either woven polyester (n  82) or expanded polytetrafluorethylene (ePTFE; n  67).
Tympanic temperature and C-reactive protein (CRP) were assessed daily during hospitalization. PIS was defined as the
composite of a body temperature of >38°C coinciding with CRP >10 mg/L. Besides graft composition, the size of the
grafts and the volume of new-onset thrombus were calculated using dedicated software, and results were correlated to
PIS.
Results: Implantation of grafts made of polyester was associated with higher postoperative temperature (P < .001), CRP
levels (P < .001), and incidence of PIS (56.1% vs 17.9%; P < .001) compared to ePFTE. After multivariate analysis,
woven polyester stent grafts were independently associated with an increased risk of PIS (hazard ratio, 5.6; 95%
confidence interval, 1.6-19.4; P .007). Demographics, amount of graft material implanted, or new-onset thrombus had
no association with PIS.
Conclusions: The composition of stent grafts may play a material role in the incidence of postimplantation syndrome in
patients undergoing EVAR. Implantation of stent grafts based on woven polyester was independently associated with a
stronger inflammatory response. ( J Vasc Surg 2012;56:1503-9.)
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sIn patients undergoing endovascular aneurysm repair
(EVAR) for an abdominal aortic aneurysm (AAA), an acute
phase inflammatory response may occur shortly after im-
plantation.1-4 This so-called postimplantation syndrome
(PIS) is defined as fever coinciding with a rise in inflamma-
tory markers.5-9 PIS is thought to be transient and harm-
less, but its true significance is unknown and no clear
guidelines exist for management.10 Importantly, the cause
of the inflammatory response remains unclear. Proposed
mechanisms are related to the introduction of the different
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http://dx.doi.org/10.1016/j.jvs.2012.06.072omponents of the stent graft11,12 or the amount of mural
hrombus within the aneurysm.13
Initial results of endovascular repair with the woven
olyester Talent Abdominal Stent Graft (Medtronic, Min-
eapolis, Minn) showed a high incidence of fever and a
ystemic inflammatory response as the most common seri-
us complication.14 Based on clinical experience, PIS
eems to be even more frequent since the recent introduc-
ion of the woven polyester Endurant Abdominal Stent
raft (Medtronic). It is not uncommon for patients to have
atigue and elevated body temperatures, sometimes for
eeks after the procedure.
For optimal management of patients with postimplan-
ation fever and rise in inflammatory markers, and to con-
ribute to future stent graft design, a better understanding
f the cause of PIS is necessary. This retrospective study
nvestigates the role of graft material on the postimplanta-
ion syndrome by comparing two types of graft material,
oven polyester and expanded polytetrafluoroethylene
ePTFE). Besides the type of material, the quantity of
mplanted graft and the association of new-onset thrombus
ith the inflammatory response are investigated.
ETHODS
Study population. The study population was derived
rom a cohort of consecutive patients undergoing an EVAR
rocedure between 2004 and 2010 at the Erasmus Univer-
ity Medical Centre, Rotterdam, The Netherlands. Exclu-
ion criteria were the concurrent use of different graft
aterials on the same patient, hybrid procedures combin-
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December 20121504 Voûte et aling endovascular with open surgical treatment, urgent
EVAR, and recent surgery or major trauma within 30 days
of the procedure. Patients with missing data on tempera-
ture or C-reactive protein (CRP) were also excluded, as
were patients who had a postoperative complication that
had an effect on inflammatory markers, including urinary
tract infections, pneumonia, and hematomas (Fig 1).
Baseline characteristics were comprised of gender, age,
and all traditional cardiac risk factors from the Revised
Cardiac Risk index,15 as well as the incidence of chronic
obstructive pulmonary disease, smoking, and hypercholes-
terolemia. Additionally, the use of medication with known
anti-inflammatory or antipyretic effects such as aspirin,
statins, and -blockers, was recorded.
According to hospital protocol, all patients underwent
an endovascular procedure with prophylactic antibiotics in
the form of 1 gram of cefazolin 30 minutes before incision,
and 5000 units of heparin before introduction of the stent
graft deployment system. Additionally, low-molecular-
weight heparin was administered in all surgical patients
during hospital admission (2500 IU dalteparin daily in all
patients, 5000 IU daily in those with a body weight over 80
kg). Type of anesthesia was selected at the discretion of the
surgical team. The study was conducted according to the
guidelines provided by the institutional review board.
Definition of endpoints. The primary endpoint of
the study was the occurrence of PIS shortly after EVAR.
PIS was defined as fever coinciding with an elevated serum
CRP level. Fever was defined as a tympanic temperature of
38.0°C, and the upper level of normal for CRP was 10
mg/L in our institutional laboratory. Tympanic tempera-
Fig 1. Flow chart of patient inclusion. AAA, Abdominal aortic
aneurysm; ePTFE, expanded polytetrafluoroethylene; EVAR, en-
dovascular aneurysm repair.ture and serum CRP levels were assessed each morning, ttarting 1 day before EVAR. Subsequent measurements
ere performed on the day of EVAR and then daily up to 4
ays after implantation. As mentioned, patients with non-
raft-related complications associated with inflammation
ere excluded from the study, including patients with
eported postoperative wound infections, pneumonia, and
nfections of the urinary tract.
Endograft composition. To evaluate the role of the
raft component of endovascular aortic devices on the
ccurrence of PIS, enrolled patients were divided into two
roups: in the first group, the graft composition was
PTFE; in the second group, both devices were composed
f a woven polyester graft. The first group was comprised of
atients exclusively treated with the low-permeability Ex-
luder AAA Endoprosthesis (WL Gore and Associates,
lagstaff, Ariz). The second group was composed of pa-
ients treated with the Talent Abdominal Stent Graft or the
ndurant Abdominal Stent Graft (both Medtronic). All
sed stent grafts were bifurcated, modular devices with a
itinol exoskeleton. An important difference between the
wo groups was that the low-permeability Excluder was
vailable since late 2004, whereas the majority of woven
olyester grafts were Endurant, which was first used in our
ospital in 2008.
Other EVAR-related causes of PIS. In addition to
he type of graft material used, the total quantity of im-
lantedmaterial may be of importance, as it may be possible
hat a certain type of graft is simply larger or more exten-
ions are used. As a marker for size, the volume inside each
raft was measured on contrast-enhanced computed to-
ographic angiography (CTA) using dedicated postan-
lysis software with central lumen line reconstructions
3mensio Vascular software; 3mensioMedical Imaging BV,
ilthoven, The Netherlands). Volume measurements were
one semiautomatically, according to a standard protocol
s described earlier.16,17
Finally, the amount of new-onset thrombus – filling the
xcluded aneurysm sac immediately after EVAR – was
easured using the same dedicated software by calculating
uminal volume before EVAR and comparing this with the
ostoperative volume measurements (Fig 2). The differ-
nce between the two measurements represents the ex-
luded sac volume, discarding any chronic mural thrombus
lready present before the procedure. For both these mea-
urements, CTA before and/or after EVAR is a necessity,
hus excluding patients without available CTAs from these
ubanalyses.
Statistical analysis. All baseline characteristics and
edication use were tabulated, as well as temperatures and
RP levels. Continuous variables were presented as means
tandard deviation or, in case of a non-Gaussian distribu-
ion, as medians and interquartile range (IQR) and com-
ared with t-test or Mann-Whitney U statistics, respec-
ively. Dichotomous variables were presented as counts and
ercentages and compared between groups using Pearson
2 statistics. The maximum body temperature and CRP
evel from the first 4 days after the procedure was compared
o the day before surgery. The changes in body temperature
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Volume 56, Number 6 Voûte et al 1505were compared for the two types of graft material using
t-test, and changes in CRP were compared by Mann-
WhitneyU statistics. To test the association of graft size and
new-onset thrombus with the postoperative rise in temper-
ature and CRP, Pearson and Spearman correlation coeffi-
cients were calculated in the total population and within
each group of graft material. Accounting for the historical
difference between groups, we calculated the conditional
probability of receiving a woven polyester graft based on
baseline characteristics using propensity score analysis. Pro-
pensity scores were generated using logistic regression with
graft material as the dependent variable. Variables included
to generate the propensity scores were all those presented as
group descriptive in Table I, complemented by the type of
anesthesia. To evaluate the association of graft material
with PIS, a propensity-adjusted binary logistic regression
analysis was performed, further correcting for statin use,
type of anesthesia, new-onset thrombus, and graft size.
Hazard ratios (HRs) and 95% confidence intervals (CIs)
were presented. All statistical tests were two-sided and
considered statistically significant when theP value was .05.
All analyses were performed using PASW statistics, version 17
for Windows (SPSS, Chicago, Ill).
RESULTS
A total of eight Talent, 74 Endurant, and 67 Excluder
Fig 2. Luminal volume calculations before and after end
aorto-iliac luminal volume measurements before (A) and
difference in luminal volume is used as a quantitative mea
aortic aneurysm.stent grafts were included in the study. This amounts to a wtudy population of 149 patients, divided in woven polyester
n  82) and ePTFE (n  67) grafts. Patients were pre-
ominantly male (87.9%) and had amean age of 72.6 7.5
ears at the time of surgery. In terms of baseline character-
stics, traditional cardiac risk factors were equally distrib-
ted among groups (Table I). The preoperative AAA diam-
ter was 59.8  11.5 mm, without significant difference
etween the two groups. When compared to the ePTFE
roup, patients in the woven polyester group had a higher
ody mass index (26.6 4.8 vs 25.1 3.2; P .026) and
ere more frequently medicated with statins (79.3% vs
4.2%; P  .040) Also, a higher proportion of patients in
he woven polyester group received general anesthesia
73.2% vs 35.8%; P  .001). Besides general anesthesia
n  84), other types of anesthesia used were spinal (n 
3), local (n  24), or a combination (n  8).
Graft type and PIS. The mean length of stay was 4.4
ays (standard deviation, 4.7 days). The incidence of PIS
as 46 (56.1%) for the woven polyester group, compared
o 12 (17.9%) in the ePTFE group (P  .001). PIS oc-
urred almost exclusively in the first 3 days after woven
olyester implantation and the first 2 days after ePTFE
mplantation.
Broken down to individual inflammatory markers, a
imilar trend was observed. On themorning before surgery,
emperatures were not significantly different between the
ular aneurysm repair (EVAR). An example of segmented
(B) endovascular repair using dedicated software. The
for new-onset thrombus after EVAR. AAA, Abdominalovasc
after
sureoven polyester and ePTFE groups (36.6 0.6°C vs 36.7
F
t
t
i
o
trafluoroethylene; SD, standard deviation.
ocedure.
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December 20121506 Voûte et al0.5°C; P .15), nor were CRP levels (5.0 [2.0-8.0] vs 3.2
[2.0-8.0]; P  .30) (Table II). In the 4 days after EVAR,
both body temperature and CRP levels rose significantly
higher in the woven polyester group compared to the
ePTFE group (Fig 3). When calculating the maximum rise
in body temperature and CRP compared to baseline for
both groups, patients that received a woven polyester graft
had a higher rise in body temperature (1.6 vs 0.9°C;
P  .001) and CRP levels (154.8 vs 38.0 mg/L;
P  .001) compared with patients that received an ePTFE
graft (Table II).
Subanalyses of graft size and new-onset thrombus.
A total of 72 patients from the woven polyester group
(87.8%) and 64 from the ePTFE group (95.5%) had avail-
able imaging for in-graft volume measurements. The mean
in-graft volume of the implanted grafts was 44.6  13.7
mL. The woven polyester group had a larger in-graft vol-
ume than the ePTFE group (50.8  13.3 mL vs 37.7 
10.6 mL; P  .001). In general, this marker for graft size
Table I. Baseline characteristics, medication use, and risk
Wove
(n
Baseline characteristics
AAA diameter, mean (mm)  SD 58.
Age, mean (years)  SD 72.
Male gender, n (%) 71
Ischemic heart disease, n (%) 32
Diabetes mellitus, n (%) 14
Renal dysfunction, n (%) 15
Cerebrovascular disease, n (%)
CHF, n (%)
COPD, n (%)
Hypercholesterolemia, n (%) 23
BMI, mean (kg/m2)  SD 26.
Creatinine, mean (mol/L)  SD 102.
Smoking, n (%) 20
Medication use
Aspirin, n (%) 49
Statin, n (%) 65
Beta-blocker, n (%) 71
AAA, Abdominal aortic aneurysm; BMI, body mass index; CHF, congestiv
polytetrafluoroethylene; SD, standard deviation.
Table II. Inflammatory markers before and after surgery b
Woven po
(n  8
Temperature (°C)
Before surgery, mean  SD 36.6 
Postoperative, mean  SD 38.2 
Difference, mean  SD 1.6 
CRP (mg/L)
Before surgery, median [IQR] 5.0 [2.0-
Postoperative, median [IQR] 164.0 [87.0
Difference, median [IQR] 154.8 [82.6
CRP, C-reactive protein; IQR, interquartile range; ePTFE, expanded polyte
Postoperative values presented are the maximum for days 1 to 4 after the prshowed a statistical correlation to the postoperative rise in Eig 3. Day by day inflammatory response after stent graft implan-
ation. Graphs display the mean  standard deviation for body
emperature and serum C-reactive protein (CRP) in relation to
mplantation of a stent graft made of woven polyester (open circles)
r expanded polytetrafluoroethylene (ePTFE) (closed circles).profile by graft material
n polyester
 82)
ePTFE
(n  67) P value
4  11.0 61.1  11.9 .22
8  7.2 72.4  7.9 .75
(86.6) 60 (89.6) .58
(39.0) 34 (50.7) .15
(17.1) 10 (14.9) .72
(18.3) 9 (13.4) .42
7 (8.5) 10 (14.9) .22
5 (6.1) 8 (11.9) .21
5 (6.1) 19 (28.4) .001
(28.0) 21 (31.3) .66
6  4.8 25.1  3.2 .026
1  38.4 97.3  32.2 .42
(24.4) 26 (38.8) .058
(59.8) 34 (50.7) .27
(79.3) 43 (64.2) .040
(86.6) 59 (88.1) .79
e heart failure; COPD, chronic obstructive pulmonary disease; ePTFE, expandedy graft material
lyester
2)
ePTFE
(n  67) P value
0.4 36.7  0.5 .15
0.7 37.6  0.7 .001
0.7 0.9  0.8 .001
8.0] 3.2 [2.0-8.0] .30
-201.0] 49.0 [20.0-104.0] .001
-198.5] 38.0 [13.7-94.0] .001VAR, Endovascular aneurysm repair.
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Volume 56, Number 6 Voûte et al 1507temperature (Pearson rho 0.29; P  .001) and CRP
(Spearman rho 0.26; P  .003). However, after stratifying
for type of material, these correlations were no longer
significant.
A total of 63 patients from the woven polyester group
(76.8%) and 46 from the ePTFE group (68.7%) had avail-
able imaging for new-onset thrombus measurements. The
mean volume of new-onset thrombus was 51.3 45.8 mL,
without significant differences between woven polyester
and ePTFE groups (50.8  45.1 mL vs 51.7  46.6 mL;
P  .91). Subsequent analyses showed no significant cor-
relation between new-onset thrombus and the rise in tem-
perature (P  .08) or CRP (P  .17).
Multivariable risk model for PIS. As mentioned,
several possible confounders of the inflammatory status of
the patients were found to be significantly different be-
tween groups. Therefore, differences in baseline character-
istics were addressed in a propensity score analysis. The
association of graft material with PIS was evaluated in a
propensity-adjusted model, additionally corrected for dif-
ferences in statin use, graft size, and new-onset thrombus.
In this analysis, the use of woven polyester remained the
only significant factor associated with an increased risk of
developing postimplantation syndrome (HR, 5.58; 95%
CI, 1.60-19.42; P  .007; Fig 4).
DISCUSSION
With the growing application of EVAR and resolution
of many significant issues related to this treatment option,
particular details and previously overlooked problems are
becoming more evident for physicians and warrant further
analysis. PIS is a clear entity that affects a significant number
of patients, but the mechanisms behind this phenomenon
have been scarcely investigated. The current study shows
that the graft type plays a primordial role in the develop-
ment of an acute phase inflammatory response after EVAR.
The implantation of stent grafts that include woven poly-
ester in their composition is associated with significant
changes in body temperature and serumCRP, compared to
those that are made of ePTFE.
The current results suggest that ePTFE has less proin-
flammatory properties than woven polyester after endovas-
Fig 4. Multivariable associations with postimplantation syn-
drome (PIS). Hazard ratios (HRs) for individual variables in the
propensity-adjusted multivariable analysis, illustrating that graft
composition was independently associated with postimplantation
syndrome. The natural logarithms of graft size and new-onset
thrombus were used. CI, Confidence interval.cular implantation in humans. This is supported by an in hitro study by Swartbol et al18 comparing the response of
uman white blood cells in vitro upon incubation with
ascular grafts of ePTFE or woven polyester. The authors
ound that woven polyester triggered a significantly larger
elease of proinflammatory markers than ePTFE.
The differences in the incidence of fever between pa-
ients who receive stent grafts of woven polyester or ePTFE
re previously described in small numbers.12 Gerasimidis et
l12 described a total of 22 consecutive EVAR patients that
eceived a woven polyester graft (n  12) or ePTFE (n 
0) and compared the incidence of fever and the postpro-
edural changes in several biomarkers. Although the study
acked the power to observe a large difference in laboratory
easurements, fever was observed more frequently in the
oven polyester group (3 of 12 patients vs 1 of 10).12
Another suggested origin for PIS is the excluded aneu-
ysm sac filling with new-onset thrombus, a process that
ay involve various proinflammatory cytokines.13 The cur-
ent study is the first to address this hypothesis in a quan-
itative manner, using dedicated software to calculate the
xcluded volume after EVAR. Data were not available for
very patient in this study, and the amount of graft material
as estimated using true, postimplantation graft volumes.
lthough both these limitations may have influenced the
esults, the measured volumes of excluded sac content in
his study showed no correlation to PIS.
There are other differences between stent grafts, unre-
ated to graft material, which may also influence the pro-
osed foreign body reaction. All stent grafts in this study
ave an exoskeleton made of nitinol, a nickel-titanium
lloy. Unlike the others, the Excluder graft features an
dditional outer layer of ePTFE covering the alloy, whereas
n the Endurant and Talent grafts, the metal and fabric are
djoined by stitches. In addition, these two latter features a
are top stent, further increasing the amount of nitinol
irectly exposed to the circulation. Apart from quantity, the
recise balance between nickel and titanium, or even the
utting and polishing, may differ between manufacturers,
otentially affecting the antigenic properties of the nitinol.
Since the introduction of nitinol for medical applica-
ion, it has been widely used in coronary and peripheral
rterial “bare-metal” stents.19 No inflammatory response is
eported in these applications, despite frequent treatment
f multiple and lengthy lesions, requiring large quantities
f the material. Furthermore, the chemical production of
itinol prevents breakdown and special coating reduces
ickel exposure.20 It is, therefore, unlikely that differences
n the application of nitinol between stent grafts may influ-
nce the postimplantation syndrome. We cannot, however,
ompletely exclude this factor using our data. The stitching
sed in the Talent and Endurant devices can also not be
uled out as a possible confounder for the inflammatory
esponse after implantation.
The hypothesis that endothelial damage, due to active
xation from the top stent, plays a role and may be dis-
issed by the current study. Evidently, if endothelial ag-
ression due to penetration of foreign material such as
ooks or barbs was key, the inflammatory response would
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the Endurant have active proximal fixation.
A final difference between stent grafts that could have
played a confounding role in the incidence of PIS is the
different delivery devices they come with. It is quite con-
ceivable that a different method of graft delivery might
affect either the rate of embolism or the duration of lower
extremity ischemia, both of which stimulate an inflamma-
tory response. Although we cannot provide data to refute
these arguments, it seems unlikely that the delivery system,
with its differences but also with many similarities, could
explain the observed difference.
Certain limitations related to our study warrant consid-
eration. First, a proportion of eligible patients had missing
information on inflammatory markers, excluding them
from this study. Although this is regrettable, such a limita-
tion is inevitable in a retrospective study. To assess if a
selection bias occurred, a comparison of baseline character-
istics was performed between included patients and ex-
cluded patients. Demographics were not significantly dif-
ferent in any parameter, rejecting the possibility of selection
bias in that regard. Coincidently, this study was not a
randomized trial. The choice of graft was not random but
based on individual parameters. This could have caused a
selection bias, although factors that influence the choice of
graft generally focus on anatomic suitability, and informa-
tion on the inflammatory response was not available at the
time. Additionally, due to chronologic differences between
groups, baseline differences were observed in possible co-
factors such as smoking but also the use of statins and
general anesthesia. These differences mostly reflect the
introduction of guidelines on perioperative treatment and
subsequent improvement of risk reduction strategies, be-
cause most woven polyester grafts were implanted in recent
years.21 Statin therapy has been especially known to atten-
uate perioperative inflammation, if administered before
surgery.22-25 However, as statin therapy was more frequent
in the woven polyester group, it could, therefore, be ex-
pected to have attenuated rather than exaggerated the
inflammatory response in this group compared to ePTFE.
To address historical differences and the nonrandomized
nature of the study, we performed a propensity-adjusted
analysis with the addition of statin use as separate covariate,
which identified the use of woven polyester as an indepen-
dent predictor of PIS compared to ePTFE. Another limi-
tation is that PIS was only measured during hospital stay.
Theoretically, PIS could have occurred in patients that were
discharged rapidly (ie, in the first 2-3 days), but patients are
generally discharged when inflammation is decreasing and
body temperatures are normal. Therefore, it is not expected
that we missed many PIS cases. Last, for the CTA-based
subanalyses, data were missing due to patient-dependent
imaging protocols. However, the available data still repre-
sent the largest cohort ever published on the subject, and
possible selection bias was not associated with the inflam-
matory endpoints of the study.ONCLUSIONS
The type of fabric used in manufacturing endovascular
tent grafts may play a material role in the development of
ostimplantation syndrome, measured by an increase in
ostprocedural body temperature and serumCRP. Accord-
ng to our findings, implantation of ePTFE-based en-
ografts results in a less pronounced inflammatory response
n comparison to those based on woven polyester.
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